C Aufrant
Impact in
- Parasitology top 1%
- Toxoplasma gondii Research Studies
- Parasitic Infections and Diagnostics
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Neonatal and Maternal Infections 4
- Co-authors
- F. Daffos (5 shared papers)P. Thulliez (3 shared papers)M Capella‐Pavlovsky (1 shared paper)Daniela Valenti (1 shared paper)Wendy L. Cox (1 shared paper)F Forestier (1 shared paper)J Couvreur (3 shared papers)F Forestier (2 shared papers)
In The Last Decade
C Aufrant
15 papers receiving 600 citations
Peers
Comparison fields: 5 of 62
- Parasitology 408
- Clinical Biochemistry 85
- Virology 47
- Epidemiology 266
- Infectious Diseases 125
Countries citing papers authored by C Aufrant
This map shows the geographic impact of C Aufrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Aufrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Aufrant more than expected).
Fields of papers citing papers by C Aufrant
This network shows the impact of papers produced by C Aufrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Aufrant. The network helps show where C Aufrant may publish in the future.
Co-authors
The 25 scholars most cited alongside C Aufrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 290 | |
| 2 | 1989 | 182 | |
| 3 | 1993 | 86 | |
| 4 | 1988 | 31 | |
| 5 | [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides]. | 1991 | 18 |
| 6 | 2009 | 16 | |
| 7 | 1980 | 11 | |
| 8 | [Brief antiseptic application of iodine in neonatal intensive care units: effects on thyroid function]. | 1994 | 6 |
| 9 | 2000 | 5 | |
| 10 | [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics]. | 1988 | 3 |
| 11 | [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)]. | 1981 | 3 |
| 12 | 1981 | 1 | |
| 13 | [Effects of cefotaxime on the intestinal bacterial ecosystem in children (author's transl)]. | 1981 | 1 |
| 14 | [Neonatal septicemias: biological diagnosis and antibiotherapy. Apropos of a series of 46 cases]. | 1991 | 1 |
| 15 | [Hemodynamic and echocardiographic investigations in children with severe meningococcosis (author's transl)]. | 1980 | 1 |
| 16 | 1999 | 0 |
About C Aufrant
C Aufrant is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Parasitology, Epidemiology and Molecular Biology, having authored 16 papers that have together received 655 indexed citations. Recurring topics across this work include Toxoplasma gondii Research Studies (4 papers), Neonatal and Maternal Infections (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Use and Resistance (2 papers), Metabolism and Genetic Disorders (2 papers), Antibiotic Resistance in Bacteria (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Fetal and Pediatric Neurological Disorders (1 paper). The work is most often cited by research in Parasitology (408 citations), Clinical Biochemistry (85 citations), Virology (47 citations), Epidemiology (266 citations) and Infectious Diseases (125 citations). C Aufrant has collaborated with scholars based in France and Canada. Frequent co-authors include F. Daffos, P. Thulliez, M Capella‐Pavlovsky, Daniela Valenti, Wendy L. Cox, F Forestier, J Couvreur, F Forestier, Patrick Hohlfeld and P. Thulliez. Their work appears in journals such as Fetal Diagnosis and Therapy, The Journal of Pediatrics, Prenatal Diagnosis, Intensive Care Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.